Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag
NCT01147809
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
130
Enrollment
INDUSTRY
Sponsor class
Conditions
Thrombocytopaenia
Interventions
DRUG:
Eltrombopag olamine
OTHER:
Placebo
Sponsor
GlaxoSmithKline